1887
Volume 2024, Issue 2
  • E-ISSN: 3008-0738

ملخص

The COVID-19 pandemic has had a profound impact on healthcare systems worldwide, necessitating adaptations in service delivery to ensure patient care and safety.

This study investigates patient and healthcare provider satisfaction at the Anticoagulant Clinic of Hamad Medical Corporation amidst the pandemic.

Data were collected through surveys conducted with patients and healthcare providers and analyzed various implemented measures such as direct oral anticoagulant (DOAC) conversion, extended international normalized ratio (INR) testing, hotline services, and telehealth consultations.

Results indicate significant patient satisfaction with DOAC conversion (75% satisfaction rate) and extended INR testing intervals (95.3% satisfaction rate), despite a minor bleeding incidence of 11%, with 3.4% experiencing moderate bleeding and 0.4% encountering life-threatening bleeding. The implementation of the hotline service garnered an 83% satisfaction rate among patients. Healthcare providers, including clinical pharmacists, perceived the implemented measures as safe, with 83.3% endorsing DOAC conversion safety and 58.3% expressing confidence in the safety of extended INR testing intervals.

This study highlights the effectiveness of patient-centered strategies in managing anticoagulation therapy during health crises such as COVID-19, emphasizing the importance of flexibility, proactive monitoring, and continuous improvement to ensure patient safety and satisfaction. These findings offer valuable insights for optimizing anticoagulation clinic operations and enhancing patient care both in times of crisis and in routine healthcare delivery settings.

Loading

جارٍ تحميل قياسات المقالة...

/content/journals/10.5339/qjph.2024.12
٢٠٢٤-١٠-٠٤
٢٠٢٤-١٠-١٦
Loading full text...

Full text loading...

/deliver/fulltext/qjph/2024/2/qjph.2024.12.html?itemId=/content/journals/10.5339/qjph.2024.12&mimeType=html&fmt=ahah

References

  1. Song F, Shi N, Shan F, Zhang Z, Shen J, Lu H, et al. Erratum in emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology. 2020; 297:(3):E346. https://doi.org/10.1148/radiol.2020209021 .
    [Google الباحث العلمي]
  2. Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine. 2020; 382:(18):1708–1720. https://doi.org/10.1056/NEJMoa2002032 .
    [Google الباحث العلمي]
  3. Ciotti M, Ciccozzi M, Terrinoni A, Jiang W-C, Wang C-B, et al. The COVID-19 pandemic. Critical Reviews in Clinical Laboratory Sciences. 2020; 57:(6):365–388. https://doi.org/10.1080/10408363.2020.1783198 .
    [Google الباحث العلمي]
  4. Thompson MG, Stenehjem E, Grannis S, Ball SW, Naleway AL, Ong TC, et al. Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings. New England Journal of Medicine. 2021; 385:(15):1355–1371. https://doi.org/10.1056/NEJMoa2110362 .
    [Google الباحث العلمي]
  5. Giri B, Pandey S, Shrestha R, Pokharel K, Ligler FS, Neupane BB. Review of analytical performance of COVID-19 detection methods. Analytical and Bioanalytical Chemistry. 2021; 413:(1):35–48. https://doi.org/10.1007/s00216-020-02889-x .
    [Google الباحث العلمي]
  6. Hendriks T, McGregor S, Rakesh S, Robinson J, Ho KM, Baker R. Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism – The SWAN study. PLOS ONE. 2020; 15:(6):e0234048. https://doi.org/10.1371/journal.pone.0234048 .
    [Google الباحث العلمي]
  7. Ng DL-C, Gan G-G, Chai C-S, Chee K-H, Tan K-L, Tan S-B, et al. Comparing quality of life and treatment satisfaction between patients on warfarin and direct oral anticoagulants: A cross-sectional study. Patient Preference and Adherence. 2019;13:1363–1373. https://doi.org/10.2147/ppa.s204246 .
    [Google الباحث العلمي]
  8. Suarez Fernandez C, Castilla-Guerra L, Cantero Hinojosa J, Suriñach JM, Acosta de Bilbao F, Tamarit JJ, et al. Satisfaction with oral anticoagulants in patients with atrial fibrillation. Patient Preference and Adherence. 2018; 19:(12):267–274. https://doi.org/10.2147/PPA.S152109 .
    [Google الباحث العلمي]
  9. Almesned A, Alqwaee A, Abusiryeh B, Almeman A. Decentralization and virtualization of INR-based anticoagulation control during the COVID-19 pandemic. Cardiovascular & Hematological Disorders – Drug Targets. 2023; 23:(3):177–182. https://doi.org/10.2174/011871529x242935231026105854 .
    [Google الباحث العلمي]
  10. Alhmoud EN, Abd El Samad OB, Elewa H, Alkhozondar O, Soaly E, El Anany R. Drive-up INR testing and phone-based consultations service during COVID-19 pandemic in a pharmacist-lead anticoagulation clinic in Qatar: Monitoring, clinical, resource utilization, and patient-oriented outcomes. JACCP: Journal of the American College of Clinical Pharmacy. 2021 May 20; 4:(9):1117–1125. https://doi.org/10.1002/jac5.1469 .
    [Google الباحث العلمي]
  11. Barnes GD, Kong X, Cole D, Haymart B, Kline-Rogers E, Almany S, et al. Extended international normalized ratio testing intervals for warfarin-treated patients. Journal of Thrombosis and Haemostasis. 2018; 16:(7):1307–1312. https://doi.org/10.1111/jth.14150 .
    [Google الباحث العلمي]
  12. Giver J, Dunn AL, Sankar A, Stanek J, Monda K, Canini J, et al. Drive-through anticoagulation clinic during the COVID-19 pandemic. The Journal for Nurse Practitioners. 2022; 18:(1):92–96. https://doi.org/10.1016/j.nurpra.2021.08.026 .
    [Google الباحث العلمي]
  13. Waterman AD, Banet G, Milligan PE, Frazier A, Verzino E, Walton B, et al. Patient and physician satisfaction with a telephone-based anticoagulation service. Journal of General Internal Medicine. 2001; 16:(7):460–463. https://doi.org/10.1046/j.1525-1497.2001.016007460.x .
    [Google الباحث العلمي]
  14. Bartholomew RR, Noble BN, Stanislaw JJ, Viehmann M, Herink MC, Furuno JP. Frequency and clinical outcomes of pharmacist-driven switching from warfarin to direct oral anticoagulants in an underserved patient population: A retrospective cohort study. American Journal of Health-System Pharmacy. 2023; 80:(Supplement_3):S103–S110. https://doi.org/10.1093/ajhp/zxac375 .
    [Google الباحث العلمي]
/content/journals/10.5339/qjph.2024.12
Loading
/content/journals/10.5339/qjph.2024.12
Loading

جارٍ تحميل البيانات والوسائط...

هذه الخانة مطلوبة
يُرجى إدخال عنوان بريد إلكتروني صالح
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error